The results of bioinformatics analysis and in vitro experiments suggested that DEPDC1 may be a key diagnostic and immunological marker, which provided a new method for investigating the pathogenesis, development and immunotherapy response of NSCLC. Here, DEPDC1 is linked to non-small cell lung carcinoma.